Hinge Health, Inc. (HNGE)

Hinge Health Stock Forecast

Stock Price Forecast

The 16 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $62.13, which forecasts a 10.91% increase in the stock price over the next year. The lowest target is $45 and the highest is $80.

Price Target: $62.13 (+10.91%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$45	$62.13	$63	$80
Change	-19.67%	+10.91%	+12.46%	+42.81%

Analyst Ratings

The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	5	6	6	6	6	6
Buy	9	10	10	10	10	10
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	17	17	17	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $53 → $63	Strong Buy	Maintains	$53 → $63	+12.46%	May 6, 2026
David Grossman Stifel	Stifel	Strong Buy Maintains $59 → $67	Strong Buy	Maintains	$59 → $67	+19.60%	May 6, 2026
Rishi Jaluria RBC Capital	RBC Capital	Buy Maintains $55 → $65	Buy	Maintains	$55 → $65	+16.03%	May 6, 2026
Saket Kalia Barclays	Barclays	Buy Maintains $52 → $62	Buy	Maintains	$52 → $62	+10.67%	May 6, 2026
Aaron Kimson Citizens	Citizens	Buy Maintains $65 → $80	Buy	Maintains	$65 → $80	+42.81%	May 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

750.64M

Increased by 27.69%

from 587.86M

Revenue Next Year

892.41M

Increased by 18.89%

from 750.64M

EPS This Year

1.94

from -7.77

EPS Next Year

2.33

Increased by 20.25%

from 1.94

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	292.73M	390.40M	587.86M	750.64M	892.41M	1.05B	1.26B
Revenue Growth	-	33.37%	50.58%	27.69%	18.89%	18.11%	19.54%
EPS	-8.31	-0.88	-7.77	1.94	2.33	2.86	3.45
EPS Growth	-	-	-	-	20.25%	22.89%	20.51%
Forward PE	-	-	-	28.94	24.06	19.58	16.25
No. Analysts	-	-	-	19	19	7	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031
High	806.0M	1.0B
Avg	750.6M	892.4M
Low	660.9M	773.1M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031
High	37.1%	34.3%
Avg	27.7%	18.9%
Low	12.4%	3.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031
High	2.63	3.24
Avg	1.94	2.33
Low	1.00	1.37

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031
High	-	67.6%
Avg	-	20.3%
Low	-	-29.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.